Progress in celiac disease research depends on the continued contributions of experienced investigators and the next generation of scientists working to advance our understanding of celiac disease. The International Society for the Study of Celiac Disease (ISSCD) and the Society for the Study of Celiac Disease (SSCD) recognize these contributions through two research awards honoring scientific achievement, leadership, and emerging talent in the field.
The Celiac Disease Foundation is proud to fund these awards in support of scientific excellence and the next generation of leaders advancing celiac disease research. The Celiac Disease Foundation would like to congratulate the recipients of the 2026 ISSCD-SSCD Prize for Excellence in Celiac Disease Research and the ISSCD-SSCD Young Investigator Prize, presented at the International Celiac Disease Symposium (ICDS) Gala Dinner on November 19 in Melbourne, Australia.
Jason Tye-Din, MBBS, FRACP, PhD, AGAF, of the Royal Melbourne Hospital, received the ISSCD-SSCD Prize for Excellence in Celiac Disease Research in recognition of his significant contributions to understanding the immune response to gluten and advancing celiac disease diagnosis and treatment. His research has helped identify the gluten peptides that trigger the disease-driving immune response and advance blood-based diagnostic approaches that could reduce the need for gluten challenges. His work has also contributed to the development of biomarkers and methods to evaluate emerging therapies, bridging fundamental immunology and clinical applications.

Laura Kivelä, MD, PhD, of Tampere University in Finland, received the ISSCD-SSCD Young Investigator Prize in recognition of her outstanding contributions to pediatric celiac disease research. Her work has advanced understanding of early disease detection, the transition from pediatric to adult care, and the long-term outcomes of celiac disease. With more than 50 peer-reviewed publications, international research collaborations, and leadership in large-scale population screening initiatives, Dr. Kivelä has established herself as an emerging leader in the field.
Please join us in congratulating both award recipients on their achievements and contributions to advancing celiac disease research.